Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05177679 · ClinicalTrials.gov registry record · NA
Enhancing Children's Cognitive Function and Achievement Through Carotenoid Consumption
A NA study of Cognitive Change and Achievement, sponsored by University of Illinois at Urbana-Champaign.
- Recruiting
- Registry status
- NA
- Development phase
- 288
- Enrollment target
- 1
- Study location
NCT05177679: Recruiting NA study of Cognitive Change and Achievement, sponsored by University of Illinois at Urbana-Champaign.
NCT05177679 is a NA study of Cognitive Change and Achievement that is actively recruiting participants, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 288 participants, above the 174-participant average among 44 other Cognitive Change trials with a reported enrollment target (66% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05177679, a NA study of Cognitive Change and Achievement, is actively recruiting participants, sponsored by University of Illinois at Urbana-Champaign.
- RECRUITING
- Registry status
- NA
- Development phase
- 288 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to test the casual relationship between carotenoid supplementation, cognitive function, and achievement over a school-year. The central hypothesis is that, relative to the waitlist placebo group, children receiving the carotenoid supplement will exhibit greater gains in cognitive function and achievement.
Primary Outcome
Changes in accuracy (%) between groups using a computerized flanker task.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo control
- DIETARY_SUPPLEMENT Active supplement
Study Locations (1)
Illinois
- University of Illinois Urbana-Champaign - Urbana
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2022-06-23 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What NCT05177679 shows while recruiting
NCT05177679 is an interventional study that assigns participants to a tested intervention. The registered 288 participants enrollment target is mid-sized for trials with a published cap, above the 174-participant average among 44 other Cognitive Change trials with a reported enrollment target (66% higher).
The record links to 3 conditions, with Cognitive Change appearing as the primary indexed condition, and to 2 interventions - of which Placebo control is the first listed.
NCT05177679 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05177679 about?
NCT05177679 is a clinical study titled "Enhancing Children's Cognitive Function and Achievement Through Carotenoid Consumption". The aim of this study is to test the casual relationship between carotenoid supplementation, cognitive function, and achievement over a school-year. The central hypothesis is that, relative to the waitlist placebo group, children receiving the carotenoid supplement will exhibit greater gains in cogn...
What is the current status of trial NCT05177679?
This trial is currently recruiting. It is a NA study. The enrollment target is 288 participants. The study started on 2022-06-23. Estimated completion is 2026-04-30.
What conditions does trial NCT05177679 study?
This clinical trial studies the following conditions: Cognitive Change, Achievement, Macular Pigmentation.
What interventions are being tested in trial NCT05177679?
The interventions under investigation include: Placebo control (DIETARY_SUPPLEMENT), Active supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05177679?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05177679 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Change
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05177679's enrollment target sits among peer trials
288 6th of 44 higher than 39 of 44 other Cognitive Change trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cognitive Change trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
-
Moderators and Mediators of Perceptual Learning
RECRUITING · NA
-
Amplitude Titration to Improve ECT Clinical Outcomes
RECRUITING · NA
-
The Role of the Time of Day in the Effects of Exercise on Memory in Heathy Young Adults
RECRUITING · NA
-
Remote Evaluation of MIND Diet
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02098265 · 288 participants · NA
A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
- NCT03741777 · 288 participants · NA
Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume
- NCT03937635 · 288 participants · Phase 3
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- NCT04621877 · 288 participants · NA
Lay-Delivered Behavioral Activation in Senior Centers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI